SpinChip is considered the ultimate concept for in vitro diagnosis analyses in a point of care setting.
Business Model:
Revenue: $0
Employees: 11-50
Address: Hoffsveien 21/23
City: Oslo
State: oslo
Zip: 0275
Country: NO
SpinChip Diagnostics will market the new state of the art platform for in vitro diagnostics point of care analyses. The technology will provide significant value by enabling faster, easier and more reliable point of care analyses at hospitals and in decentralized medical settings. The fully automated device analyses blood samples within a few minutes. The company will initially focus on the rapid cardiac segment. A Troponin-I analysis is under development and the portfolio will swiftly be broaden to a cardiac panel. The SpinChip platform will deliver the same quality as the very best high-sensitivity central laboratory analyzers, thus making the customer value proposition significantly more attractive than competing point of care platforms.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2021 | Private Placement | $16.1M | 6/2013 | Seed Round | 1 | - |
SINTEF Venture AS SINTEF Venture AS |
1/2016 | Venture Round | 1 | $2.1M |
Investinor Investinor |
6/2013 | Seed Round | 1 | - |
SINTEF Venture AS SINTEF Venture AS |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|